Seeing Is Believing

Currently out of the existing stock ratings of Sean Wieland, 292 are a BUY (80%), 63 are a HOLD (17.26%), 10 are a SELL (2.74%).
Analyst Sean Wieland, carries an average stock price target met ratio of 69.55% that have a potential upside of 27.47% achieved within 298 days. Previously, Sean Wieland worked at PIPER SANDLER.
Sean Wieland’s has documented 744 price targets and ratings displayed on 42 stocks. The coverage was on Healthcare, Technology, Consumer Defensive, Basic Materials, Consumer Cyclical sectors.
Most recent stock forecast was given on OMCL, Omnicell at 03-May-2022.
Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 12/9/2020. The price target of $56 was fulfilled within 1 day with a profit of $3.39 (6.44%) receiving and performance score of 64.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-May-2021
$12
$0.1 (0.84%)
$7.5
Buy Since 07-Aug-2025
$16
$4.1 (34.45%)
$9
Hold Since 02-Nov-2023
$8
$-1.19 (-12.95%)
$10
Hold Since 13-Feb-2025
$5
$-4.19 (-45.59%)
$8
Hold Since 02-Nov-2023
$6
$0.72 (13.64%)
$10.5
What Year was the first public recommendation made by Sean Wieland?